Medica SurB de CVMSURF 84 3-Year RORE % is -72.78 as of Dec. 2025. GuruFocus rates MSURF with a GF Score™ of 84/100 and a GF Value™ of $0.53. The stock has 6 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Medica SurB de CV ranks better than 97.69% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Medica SurB de CV's 3-Year RORE % for the quarter that ended in Dec. 2025 was -72.78%.
The industry rank for Medica SurB de CV's 3-Year RORE % or its related term are showing as below:
MSURF's 3-Year RORE % is ranked better than 97.69% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: -0.32
vs MSURF: -72.78
Medica SurB de CV (OTCPK:MSURF) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Medica SurB de CV 3-Year RORE % Related Terms
Medica SurB de CV 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Medica SurB de CV's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medica SurB de CV's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medica SurB de CV 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Medica SurB de CV's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Medica SurB de CV (MSURF) has a 3-Year RORE % of -72.78 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Medica SurB de CV and its competitors. According to the industry distribution chart, Medica SurB de CV ranks #14 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 2.3%.
Is Medica SurB de CV's 3-Year RORE % too high?
Medica SurB de CV's current 3-Year RORE % is -72.78. Based on the distribution chart, Medica SurB de CV ranks #14 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medica SurB de CV has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #14 out of 605 companies for 3-Year RORE %. This places Medica SurB de CV in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Medica SurB de CV and its competitors. Medica SurB de CV's current 3-Year RORE % is -72.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Medica SurB de CV (MSURF) has a current 3-Year RORE % of -72.78. The stock's GF Value™ is $0.53, compared to a current price of $0.67 — trading 27% above its estimated fair value. The current 3-Year RORE % is -72.78. Medica SurB de CV's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Medica SurB de CV (MSURF), the current 3-Year RORE % is -72.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MSURF) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of $0.67 is trading 27% above its estimated GF Value™ of $0.53.
Key valuation signals for MSURF:
3-Year RORE %: -72.78
GF Value™: $0.53 vs. price of $0.67 (27% above fair value)
No single metric tells the full story. See the MSURF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
84GF Score
Get the complete analysis for MSURF
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSURF has been successfully added to your 
